Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
FDA labeling for EGRIFTA WR states that tesamorelin is indicated for reducing excess abdominal fat in HIV-infected adults with lipodystrophy, while also noting that it is not indicated for weight-loss management and that long-term cardiovascular safety has not been established. For a research comparison article, Tesamorelin gives useful context: it shows that the GHRH analog category is not limited to CJC-1295 and Sermorelin
Contains sulfites
- Modulation of the depigmenting abilities of other melanocytotoxic agents
The results were actually quite remarkable 64% of women taking ALC+Clomid ovulated versus 17% of those taking Clomid alone, the number of mature follicles was an average of 2.2 in the ALC+C group versus 0.16 in the Clomid only group, fewer days were needed for follicular maturation, uterine lining was thicker by more than 3mm (that is HUGE, especially given the propensity of Clomid to thin the lining!!), progesterone during the luteal phase was 30% higher, and the pregnancy rate was 49% with ALC+Clomid versus 1% with Clomid alone
Diabetes is the most common identifiable cause of small fiber neuropathy
Brashears et al., 1998)
